Abstract
Diabetes (DB) is a risk factor for osteoarthritis progression. High glucose (HG) is one of the key pathological features of DB and has been demonstrated to induce apoptosis and senescence in chondrocytes. Autophagy is an endogenous mechanism that can protect cells against apoptosis and senescence. The effects of HG on autophagy in cells including chondrocytes have been studied; however, the results have been inconsistent. The current study aimed to elucidate the underlying mechanisms, which could be associated with the contrasting outcomes. The present study revealed that HG can induce apoptosis and senescence in chondrocytes, in addition to regulating autophagy dynamically. The present study demonstrated that HG can cause oxidative stress in chondrocytes and suppress the AMPK pathway in a dose-dependent manner. Elimination of oxidative stress by Acetylcysteine, also called N-acetyl cysteine (NAC), downregulated autophagy and alleviated HG-stimulated apoptosis and senescence, while activation of the AMPK signaling pathway by AICAR not only upregulated autophagy but also alleviated HG-stimulated apoptosis and senescence. A combined treatment of NAC and AICAR was superior to treatment with either NAC or AICAR. The study has demonstrated that HG can suppress autophagy through the AMPK pathway and induce autophagy via oxidative stress in chondrocytes.
Subject terms: Autophagy, Bone, Endocrine system and metabolic diseases
Introduction
Osteoarthritis (OA) is a prevalent and irreversible disease of the joints, which causes considerable individual suffering and a heavy social burden globally1. The primary features of OA are articular cartilage disruption, subchondral bone remolding, and synovitis, leading to pain, stiffness, and motor disability among others. The occurrence and development of OA is influenced by various risk factors such as diabetes (DB), heredity, obesity, and trauma2–4. Numerous studies have established that DB is a key factor that adversely influences the onset of OA and exacerbates OA symptoms5–7. According to the American Diabetes Association, DB is a type of metabolic disease characterized by hyperglycemia due to defects in insulin secretion, insulin action, or both4. Chronic hyperglycemia of DB may trigger long-term joint damage and dysfunction. Previous studies on articular tissues have demonstrated the adverse influence of DB on biochemical and biomechanical changes in joints and described the pathological manifestation and molecular mechanisms activated in high-glucose environments, which could cause OA8–13. With the increasing prevalence of DB and OA14,15, an increasing number of researchers have begun to focus on the precise molecular mechanisms of DB on OA, although the pathogenesis and underlying mechanisms have not been completely understood.
Autophagy is an intracellular degradation mechanism that plays a critical role in maintaining cellular integrity and survival by eliminating unnecessary proteins and impaired organelles16,17. Autophagy is a key process in normal articular cartilage; therefore, its disease-related loss is closely associated with OA18,19. Autophagy dysfunction can be attributed to the effect of high glucose (HG), with a low rate of cell turnover and poor regenerative capacity19,20. A few studies on the association between autophagy and DB-related diseases have been performed. For example, a previous study conducted by our research group revealed that DB can cause intervertebral disc degeneration by accelerating apoptosis and senescence of nucleus pulposus cells and that autophagy as a response mechanism can be upregulated in diabetic rats with degenerated intervertebral discs21. In OA, a converse outcome of defective autophagy was observed in diabetic patients with OA and experimental mice, suggesting that HG could compromise autophagy capacity in diabetic patients with OA22,23. The studies revealed contrasting results for in vivo experiments because the effects of DB on autophagy rather than HG could be attributed to several factors such as aging, inflammation, vascular injury, etc24,25. Notably, in vitro studies attempted to determine whether HG led to inhibition or activation of autophagy. HG resulted in decreased LC3II levels and elevated p62 levels in vascular smooth muscle cells24; similarly, inhibition of HG-mediated autophagy was observed in the human neuroblastoma cell lines25. By contrast, Zhao et al. established that excessive autophagy in H9c2 cells was induced in a HG medium26. Furthermore, two studies reported that high concentrations of glucose facilitated autophagy activation in trophoblast cell lines and the cardiomyocyte cell lines27,28. To the best of our knowledge, the effects of HG on autophagy in chondrocytes remain indeterminate.
Therefore, the aim of the present study was to investigate the effects of HG on autophagy and related mechanisms using various concentrations of HG to stimulate primary articular chondrocytes and to provide a novel and promising strategy for preventing DB-induced OA.
Results
Effects of HG on autophagy, apoptosis, and senescence in chondrocytes
Cells were treated with various concentrations of glucose (5.6, 12.5, 25, and 50 mM) for 24 h to investigate the effects of HG on chondrocytes. The effect of HG on autophagy was assessed by Western blot and the results revealed that p62 level was remarkably upregulated, whereas LC3II/I level was remarkably downregulated with an increase in the concentration of glucose, suggesting that HG inhibited autophagy (Fig. 1A). However, p62 and LC3II/I levels decreased in chondrocytes treated with 50 mM glucose when compared with chondrocytes treated with 25 mM glucose, suggesting that the effect of HG on autophagy in rat chondrocytes was variable and dose-dependent.
The expression of senescence-related markers (p53, p21, and p16) increased markedly with increase in glucose concentration (Fig. 1B). SA-β-gal staining results revealed that HG significantly increased the number of SA-β-gal-positive cells in a concentration-dependent manner (Fig. 1C). In addition, Western blot analysis revealed that cleaved caspase-3 and Bax (the pro-apoptotic index) increased considerably, while Bcl-2 (the anti-apoptotic index) decreased with increasing glucose concentrations (Fig. 1D). Furthermore, TUNEL assay demonstrated the HG induced apoptosis of chondrocytes in a concentration-dependent manner (Fig. 1E, F). The results suggested that HG not only accelerates senescence but also promotes apoptosis in rat chondrocytes in a concentration-dependent manner.
HG induces oxidative stress and suppresses AMPK signaling in chondrocytes
HG has been reported to induce cellular damage through oxidative stress29,30; HG is a primary source of cellular energy, which may suppress a key energy-sensing pathway, the AMPK pathway31,32. Oxidative stress and the AMPK pathway have been demonstrated to be associated with autophagy33,34. Therefore, we evaluated the effects of HG on oxidative stress and the AMPK pathway.
DCFH-DA is a specific probe for intracellular ROS. The DCFH-DA staining assay (Fig. 2A, B) revealed that HG induced higher-ROS levels in a concentration-dependent manner. Western blot results revealed that the ratio of p-AMPK/AMPK decreased in a concentration-dependent manner (Fig. 2C, D). The results suggested that HG can influence chondrocytes by inducing oxidative stress and suppressing AMPK signaling.
Elimination of oxidative stress suppresses autophagy and inhibits apoptosis and senescence in HG-treated chondrocytes
NAC is an antioxidant that has been used to prevent the production of ROS in chondrocytes35. We initially detected the cytotoxicity of NAC in chondrocytes at various glucose concentrations using the Cell Counting Kit-8 (CCK-8) assay after 24 h of treatment with NAC (Supplementary 1A). The CCK-8 assay results demonstrated that treatment of chondrocytes with NAC for 24 h exerted a negative effect on the viability of chondrocytes over the concentration of 1 mM; therefore, 1 mM NAC was used in subsequent experiments. We evaluated ROS levels in HG-treated chondrocytes in combination with or without NAC to elucidate the role of NAC in HG induced chondrocytes. The results revealed that DCFH-DA positive cells with green fluorescence and DCFH-DA fluorescence intensity increased substantially under HG induced oxidative stress, which was reversed by the administration of NAC (Fig. 3A, B). The results demonstrated that NAC can significantly reduce oxidative stress in HG induced rat chondrocytes.
ROS production as an indicator of oxidative stress is widely recognized as a key mediator of autophagy33,36. The increase in ROS level can promote autophagy activation. We evaluated the expression levels of p62 and LC3II/I to explore the effect of oxidative stress elimination on autophagy in HG induced rat chondrocytes (Fig. 3C). Western blot results revealed that autophagy was suppressed in HG induced chondrocytes, and further suppressed upon treatment with NAC, suggesting that elimination of oxidative stress (NAC) suppresses autophagy in HG induced chondrocytes. In addition, the effect of NAC on apoptosis and senescence was evaluated. The levels of senescence-related markers (p53, p21, and p16) and classical pro-apoptotic markers (C-caspase-3 and Bax) were downregulated in NAC-treated groups. The anti-apoptotic index (Bcl-2) increased (Fig. 3D, E). The results suggest that elimination of oxidative stress (NAC) suppresses autophagy, and can inhibit apoptosis and senescence in HG induced rat chondrocytes.
Activation of AMPK promotes autophagy and suppresses apoptosis and senescence in HG-treated chondrocytes
AICAR has the capacity to activate AMPK in chondrocytes37; therefore, we used AICAR to assess the effect of AMPK activation on autophagy, as well as its cytoprotective effects against apoptosis and senescence in chondrocytes. We initially evaluated the cytotoxicity of AICAR at various concentrations in chondrocytes using CCK-8 assay after 24 h of treatment with AICAR (Supplementary 1B). The CCK-8 assay results demonstrated that a concentration of 1 mM AICAR was the optimum concentration for chondrocytes. HG-stimulated cells were either treated with or without AICAR to explore the capacity of AICAR to activate AMPK in rat chondrocytes. Western blot analyses results revealed that HG decreased the phosphorylation level of AMPK, whereas AICAR increased the phosphorylation level of AMPK, suggesting that AICAR has the capacity to activate AMPK in HG induced chondrocytes (Fig. 4A). A decreased expression of p62 and increased expression of LC3II/I were observed in AICAR-treated groups, which suggested that activation of AMPK promoted autophagy in HG induced chondrocytes (Fig. 4A). Furthermore, we established that the levels of senescence-related and pro-apoptotic markers were increased, whereas Bcl-2 level decreased in AICAR-treated groups when compared with the HG treated group (Fig. 4B, C). The results suggested that activation of AMPK (AICAR treatment) promotes autophagy, and suppresses apoptosis and senescence in HG induced chondrocytes.
Combined treatment of NAC and AICAR is superior to treatment with either NAC or AICAR
In vitro experiments
Cells were treated with a combination of NAC and AICAR to evaluate the capacity of dual modulation effects of oxidative stress and AMPK on chondrocytes. Western blot analyses results revealed that p62 expression levels decreased and LC3II/I expression levels increased in the HG-treated group when compared to the NAC + AICAR-treated group, which demonstrated an overall activation of autophagy (Fig. 5A). In addition, autophagy in the NAC + AICAR-treated group decreased when compared with the NAC-treated group but increased autophagy when compared with the AICAR-treated group. The levels of senescence-related and apoptosis-related markers decreased, while Bcl-2 level increased in the NAC + AICAR-treated group when compared with the NAC group (Fig. 5B–E). Similar results were observed in the AICAR group except for p16. Strikingly, anti-senescence and anti-apoptotic effects were greater in the AICAR group than in the NAC group. Generally, the results suggested that combined treatment of NAC and AICAR promoted autophagy, and suppressed apoptosis and senescence in HG induced rat chondrocytes; combined treatment of NAC and AICAR was superior to treatment with either NAC or AICAR in vitro.
In vivo experiments
To investigate the protective effects of NAC and AICAR on DB-accelerated OA in vivo, the DB–OA model was established. The X-ray revealed that the DB-DMM group exhibited formation of severe osteophytes, narrowing of joint spaces, and an increase in cartilage surface density when compared with the DMM group. However, the pathological changes were mild in the treatment groups and the combined treatment was superior to treatment with either NAC or AICAR (Fig. 6A). Histological analyses were performed by staining mice cartilage with safranin O (Fig. 6B). The OARSI scores of the five groups were as follows: DMM = 4.000 ± 1.309, DB-DMM = 9.625 ± 1.302, DB-DMM + NAC = 8.375 ± 0.744, DB-DMM + AICAR = 6.500 ± 1.195, and DB-DMM + NAC + AICAR = 4.000 ± 1.773 (Fig. 6C). The subchondral bone thicknesses in the five groups were as follows: DMM = 210.0 ± 41.4, DB-DMM = 387.5 ± 26.1, DB-DMM + NAC = 350.0 ± 38.5, DMM + AICAR = 321.3 ± 32.3, and DMM + NAC + AICAR = 215.0 ± 3.4 (Fig. 6D). Synovial thickening and hypercellularity in the five groups were as follows: DMM = 2.125 ± 0.835, DB-DMM = 5.000 ± 0.926, DMM + NAC = 4.125 ± 0.641, DMM + AICAR = 3.750 ± 1.035, and DMM + NAC + AICAR = 2.750 ± 0.707 (Fig. 6E). The results suggested that NAC and AICAR ameliorated DB–OA progression in vivo and that the combined treatment of NAC and AICAR was superior to treatment with either NAC or AICAR in vivo.
Discussion
OA is a chronic and widespread disease, which is a principal cause of disability among the elderly, in turn, resulting in high social costs. As the population ages and the population with DB increases, OA has increasingly become prevalent over the last few decades19,38. Epidemiological studies conducted recently and experimental evidence have demonstrated that DB can induce the occurrence of OA and exacerbate the burden associated with OA1,39,40. Diabetic patients with OA are prescribed non-steroidal anti-inflammatory drugs or muscle relaxants to relieve symptoms; however, few drugs and treatment strategies are available for DB–OA progression. Presently, a few studies on the underlying mechanisms of DB or HG that influence OA progression have been performed. The present study revealed that HG can suppress autophagy through the AMPK pathway and induce autophagy via oxidative stress in chondrocytes in vitro. In addition, NAC and AICAR can ameliorate DB–OA progression in vivo, and the therapeutic effect of combined treatment was superior to individual drug treatments.
Alteration of autophagy-related proteins leads to the destruction of the articular cartilage that ultimately causes entire joint damage and the development of OA18. HG can considerably influence the level of autophagy; however, the results were inconsistent. A study by Ribeiro et al. revealed that HG inhibited autophagy to accelerate cartilage degradation, and pharmacological autophagy activation inversely attenuated the harmful effects on chondrocytes22. Adversely, other studies reported that autophagy as a response mechanism was upregulated to offer protection against HG-induced apoptosis and senescence, which means completely reverse result21,26,41. In the present study, the results of in vitro experiments revealed that autophagy levels changed dynamically with increase in glucose concentration. Therefore, we hypothesized that HG influenced autophagy via two distinct mechanisms at various glucose concentrations. The first hypothesis was that HG decreased autophagy to negatively influence chondrocytes via a certain pathway, and the second hypothesis was that HG increased autophagy as a response mechanism to protect from cellular damage via a different pathway. Therefore, the present study focused on investigating the two mechanisms involved in autophagy.
In the late 1990s, the “radical free” concept was posited42. Living cells can be influenced by the harmful effects of exogenously or endogenously produced high concentrations of reactive oxidizing molecules29,30. Among the molecules, ROS has been identified as a key oxidizing molecule with biological influence36. HG, which is a risk factor for DB, can rapidly increase energetic stress in cells, cause mitochondrial overburden and electron leakage, and eventually increase the production of oxidized molecules.36HG can generate oxidized molecules to induce oxidative stress and HG-induced oxidative stress results in cell damage29,43–45. Our results were consistent with the findings of previous studies. The level of HG-produced ROS in chondrocytes activated apoptosis and senescence in a concentration-depend manner, which was significantly reversed by the antioxidant, NAC.
In addition, oxidative stress is a key factor influencing autophagy33,46–48, and ROS has been considered an early inducer of autophagy49. Superoxide anion (O2−) and H2O2 are the principal forms of ROS produced by various stimulants including HG and are crucial in the activation of autophagy because treatment with antioxidants partially or completely reverses the effect50. According to a previous study, elevated ROS level was observed in axons after hypoxic-ischemic injury, and activation of autophagy in the striatum and cortex was observed in adult and neonatal mice51. Another study revealed that ROS following cerebral hypoxia-ischemia induced autophagy to eliminate injured mitochondria and prevent necrosis52,53, which was consistent with the findings of the present study. The present study demonstrated that HG stimulated oxidative stress, which in turn, induced the production of ROS, although the decrease in autophagy was further enhanced by NAC, implying that HG partially increased autophagy in chondrocytes via oxidative stress. Therefore, autophagy, which functioned as a feedback regulation mechanism, was considered to be a protective mechanism associated with HG stimulation. Although the specific mechanisms were not elucidated in this study, activation of autophagy by ROS could be attributed to the following reasons. First, ROS is transduced by a ROS-producing system located in or adjacent to the plasma membrane, such as the NADPH oxidase (NOX) complexes. ROS produced by NOX2 are essential for the recruitment of microtubule-associated protein LC3 on phagosomes54. Second, mitochondria are the primary sites of ROS generation and are the organelles with the capacity to activate and regulate autophagy; thus, mitophagy could play a pivotal role in cellular autophagy. The impairment of mitochondrial function caused by HG in cells results in the production of large quantities of ROS, which suggests that mitophagy is a key factor influencing response to oxidative stress. The mitochondria-selective process of mitophagy can be modulated by certain proteins, including BNIP3 (BCL2/adenovirus E1B 19 kDa interacting protein 3), PARK2, PINK1 (PTEN-induced putative kinase 1), and mitochondrial fusion and fission processes55–57. Finally, ROS, especially H2O2, can bind to the cysteine 81 site of ATG4 to directly activate ATG4 and lipidation of LC333,58, which is a vital process for the formation of autophagosomes. After autophagosomes mature and fuse with lysosomes, ATG4 delipidates LC3. However, H2O2-mediated oxidation of ATG4 can inactivate delipidization of LC3 during the process. A detailed study by Rodriguez-Muela and colleagues demonstrated that Atg4B−/− mice exhibited a marked reduction of LC3 and an increased SQSTM1 level59.
AMPK is a genuine sensor of the energy status of cells, which can be inhibited in HG environments34,60,61. At the molecular level, the AMPK signaling pathway is extensively considered to be a key factor influencing the stimulation of autophagy. In the present study, the AMPK signaling pathway and autophagy were significantly inhibited, and apoptosis-related and senescence-related markers were significantly upregulated when chondrocytes were treated with HG concentrations; the phenomena were reversed by AICAR. The results suggest that HG causes apoptosis and senescence in chondrocytes by inhibiting autophagy through the AMPK signaling pathway.
Additionally, there could have been a crosstalk between oxidative stress and the AMPK pathway when HG stimulated chondrocytes at a certain glucose concentration. Particularly, the regulation of ROS as a product of oxidative stress in the AMPK pathway in various types of cells has been contradictory. A few researchers have argued that oxidative stress can damage the mitochondrial structure, which results in energy imbalance. AMPK is a crucial sensor of cellular energy that can be activated by ROS53 and mTOR is subsequently inhibited to activate autophagy. However, a study by Jiang et al. demonstrated that ROS induced by HG facilitated the recruitment of MG53 and subsequent degradation of p-AMPKα at S485/49162. Moreover, HG deactivated AMPK, which was associated with ROS-dependent suppression of AMPKα phosphorylation at T172 rather than ATP level62. According to the results of the present study, the AMPK pathway was inhibited by HG, which implied that ROS did not activate AMPK to increase autophagy. Furthermore, ROS was demonstrated to increase autophagy, which suggested that ROS-dependent suppression of AMPK was insignificant or did not occur. Therefore, the crosstalk may not be vital in the regulation of autophagy in HG-stimulated chondrocytes.
Overall, the present study revealed that HG-induced autophagy is the synthetic results via two different mechanisms; the first mechanism is autophagy activation by oxidative stress and the second mechanism is autophagy inhibition via the AMPK signaling pathway (Fig. 7). AMPK signaling pathway plays a major role in decreasing autophagy in chondrocytes relative to oxidative stress. The effect of oxidative stress associated with autophagy activation is significantly enhanced with an increase in glucose concentration; therefore, the overall autophagy was inversely upregulated.
The present study provides a novel strategy for treating DB-accelerated OA. Although several researchers have focused on the pharmacological activation of autophagy via the AMPK signaling pathway to attenuate adverse effects of HG, pharmacological remission of oxidative stress should not be overlooked. In vivo and in vitro experiments revealed that NAC and AICAR effectively alleviated senescence and apoptosis in HG-induced chondrocytes. Moreover, combined treatment of NAC and AICAR was superior to treatment with either NAC or AICAR. We observed that the role of AICAR seemed superior to that of NAC and that the p16 level in the NAC + AICAR group was significantly lower than that in the NAC group, although not significantly different when compared with the AICAR group. The observations could be because AICAR not only increased autophagy to alleviate senescence and apoptosis but also ameliorated oxidative stress based on increased autophagy to enhance its roles. Furthermore, the combined application of other antioxidants and AMPK activation agents to replace these drugs can be an alternative.
The present study had a few limitations. First, we did not investigate the specific mechanisms associated with the two pathways in detail; therefore, the specific molecular changes were obscure except for p-AMPK. In addition, the specific mechanisms elucidating the role of ROS in autophagy remain unknown. Second, the long-term therapeutic effects and side effects of the combined treatment in DB-accelerated OA are indeterminate and require further study.
Conclusion
The present study has demonstrated that high glucose suppresses autophagy through the AMPK signaling pathway and induces autophagy via oxidative stress in chondrocytes. The combined treatment of NAC and AICAR is a novel and potential strategy for treating DB-accelerated OA.
Materials and methods
Reagents and antibodies
Primary antibodies including p62 (ab109012), LC3 (ab62721), B-cell lymphoma 2 (Bcl-2, ab196495), p16 (ab51243), p21(ab109199) and β-actin (ab6276) were acquired from Abcam (Cambridge, MA, USA). Primary antibodies against p-AMPK (50081), AMPK (5831), Bax (2772), and p53 (2524) were purchased from Cell Signaling Technologies (CST; Danvers, MA, USA). Primary antibodies against cleaved caspase-3 (C-caspase-3, WL01992) were purchased from WanleiBio (Shen Yang, China). Goat anti-rabbit IgG (7074) and goat anti-mouse IgG (7076) secondary antibodies were purchased from CST (Danvers, MA, USA). Cell culture reagents were purchased from Gibco (Grand Island, NY, USA). D-(+)-Glucose was purchased from Sigma-Aldrich (St. Louis, MO, USA). AICAR and Acetylcysteine also called N-acetyl cysteine (NAC) were acquired from MedChemExpress (MCE; Manmouth Junction, NJ, USA).
Isolation and culture of rat chondrocytes
Sprague–Dawley rat articular cartilage was collected from the underlying bone and connective tissues of 5-day-old rats. The cartilage tissues were cut into 1 × 1 × 1 mm3 pieces and washed three times with phosphate-buffered saline (PBS). The tissues were subsequently digested in 0.2% type II collagenase (Sigma-Aldrich, St. Louis, MO, USA) for 4 h at 37 °C. After washing with PBS, the digested tissues were transferred into a mixed medium containing 1 g/L D-Glucose, which included Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Gibco, Invitrogen, Grand Island, NY, USA) with 15% fetal bovine serum (FBS; Gibco, Invitrogen, Grand Island, NY, USA) and antibiotics (1% penicillin-streptomycin), and incubated in 5% CO2 at 37 °C. When confluent, the cells were passaged after treatment with 0.25% trypsin-EDTA (Gibco, Invitrogen, Grand Island, NY, USA) and reseeded into 10-cm culture plates at the appropriate density under a humidified atmosphere. We only used passages three or four in our experiments.
Experimental design
In vitro experiments
Normal rat chondrocytes were cultured in glucose concentration of 5.6 mM, which was similar to the normal blood sugar level. Chondrocytes were incubated at different glucose concentrations (12.5, 25, and 50 mM) to simulate HG stimulation in vitro. In addition, chondrocytes treated with a glucose concentration of 50 mM were selected as the HG group in subsequent analyses. The group treated with 50 mM HG was either treated with or without AICAR (1 mM), with or without NAC (1 mM). Cells were harvested after 24 h of incubation.
In vivo experiments
Male C57BL/6 mice (8 weeks old) were randomly divided into five groups with 8 mice in each group, and the selection of sample size for animal experiments is carried out as per the preliminary experiments as well as similar well-designed experiments22. The mice were operated through surgical destabilization of the medial meniscus (DMM): with AICAR), and group E (DMM treated with NAC and AICAR). After fasting for 10 h, the mice were injected intraperitoneally with 0.1 mol/L streptozotocin (STZ) at a dose of 100 mg/kg/day until blood glucose concentration was >16.7 mmol/L, which should be stable for at least 5 days. Afterward, the mice were fed with high-fat and high-sugar diets (HFSD) for 4 weeks to establish DB models. The DB mice subjected to DMM were considered as the DB-accelerated OA models (DB-OA models)22. Mice in the remaining groups except for the control group were fed with HFSD. Mice in the treatment groups were injected intraperitoneally with AICAR at a dose of 200 mg/kg/day or received an intro-articular injection of NAC at a dose of 5 mg/kg/3 days based on previous studies63–65. All mice were euthanized 4 weeks after surgery and the cartilage tissues were used for iconographic and histological analyses.
Western blot assay
Chondrocytes were lysed in ice-cold radioimmunoprecipitation assay buffer with 1 mM phenylmethanesulfonyl fluoride and centrifuged at 4 °C and 12,000 rpm. The protein concentrations were quantified using the BCA Protein Assay Kit (Beyotime Biotechnology, Shanghai, China). Protein samples were separated using sodium dodecylsulfate-polyacrylamide gel electrophoresis and subsequently transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA). The membranes were blocked with 5% nonfat milk for 1.5 h and probed with primary antibodies against p62 (1:1000), LC3 (1:1000), β-actin (1:2000), p-AMPK (1:1000), C-caspase-3 (1:500), Bax (1:1000), Bcl-2 (1:1000), p53 (1:1000), p21 (1:1000), and p16 (1:1000) overnight at 4 °C before incubating with the respective secondary antibodies for 2 h at room temperature. Finally, the intensities of protein bands were quantified using Image Lab software (version 3.0; Bio-Rad, Hercules, CA, USA).
Senescence–associated β-galactosidase (SA-β-gal) staining
Cells were fixed on plates with 0.2% glutaraldehyde for 15 min after washing them three times with PBS. Subsequently, cells were stained using an X-gal staining solution at a pH of 6.0 and incubated overnight. The images were captured by Olympus IX71 microscope (Olympus Inc., Tokyo, Japan). Finally, the percentages of SA-β-gal-positive cells were counted for subsequent statistical analysis.
TUNEL assay
DNA fragmentations resulting from apoptosis were measured using the terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay. After fixing with 4% paraformaldehyde for 1 h, cells were incubated with 3% hydrogen peroxide (H2O2) and 0.1% Triton X-100 for 10 min. The cells were stained using the In Situ Cell Death Detection Kit (F. Hoffmann-LaRoche Ltd., Basel, Switzerland) and 4, 6-diamidino-2-phenylindole (DAPI). Finally, slides were imaged using a fluorescence microscope (Olympus Inc., Tokyo, Japan).
Reactive oxygen species assay
The reactive oxygen species (ROS) level in cells were measured using 2′,7′-dichlorodihydro-fluorescein diacetate (DCFH-DA) Staining Assay Kit (Beyotime Biotechnology, Shanghai, China). Chondrocytes in plates were incubated with DCFH-DA mixed basic culture medium (1:1000) for 30 min based on the previous experimental procedures66. Finally, the random fields were captured by fluorescence microscopy (Olympus Inc., Tokyo, Japan). The results of relative fluorescence unit (RFU) values were calculated by subtracting the blank well values from the RFU values of the assay wells, which were detected at 490/520 nm by a multifunction fluorescence microplate reader.
X-ray imaging
Mice in five groups were examined with X-ray 4 weeks after surgery to assess the joint spaces, osteophyte formation, and calcification changes using a digital X-ray machine (Kubtec Model XPERT.8; KUB Technologies Inc.). Suitable images were obtained in the following settings: 50 kV and 160 μA.
Histopathological analysis
The joint tissues of mice were fixed with 4% paraformaldehyde for 2 days and decalcified in neutral 10% EDTA solution for 2 weeks. Subsequently, the samples were cut into 5-µm slides. The slides were deparaffinized in xylene and rehydrated in ethanol washes. Slides with joint tissues from five groups were subjected to safranin O-fast green (S–O) staining. The cellularity and morphology of the cartilages were blindly evaluated by three experienced histology researchers using the Osteoarthritis Research Society International (OARSI) scoring system as described previously67. The synovitis and subchondral cortical bone thickness were graded as described previously5,68,69. The AxioVision software (Zeiss, Oberkochen, Germany) was used to measure the thickness of the medial subchondral bone plate.
Statistical analysis
Statistical analyses were performed using SPSS statistical software version 22.0 (SPSS, Inc., Chicago, IL, USA). All experiments were repeated at least five times. The results were presented as means ± standard deviation (SD). For parametric data, the differences among four groups were analyzed by one-way analysis of variance (ANOVA), and the differences between the two groups were analyzed by t-test. The nonparametric data were analyzed using the Kruskal–Wallis H test. P value < 0.05 was considered statistically significant.
Supplementary information
Acknowledgements
We thank all the colleagues for their invaluable assistance during the execution of this study.
Author contributions
X.Z., X.W. and Z.H. were involved in the conception and design of the research. B.W., Y.S., J.C., Z.S., L.N., Y.L., Y.W., N.T., Y.Z., L.S. and A.W. provided assistance for data acquisition. B.W., X.W. and X.Z. participated in the analysis and interpretation of data. B.W. and Y.S. carried out paper editing and supplementary experiment. All authors have read and approved the content of the paper.
Funding
This study was supported by grants from the National Natural Science Foundation of China (81871806), Zhejiang Provincial Natural Science Foundation of China (LY18H060012, LGF20H060013), Wenzhou Science and Technology Bureau Foundation (ZY2019014, Y2020059); Lin He’s New Medicine and Clinical Translation Academician Workstation Research Fund (18331213), and Zhejiang Provincial Project for Medical Health Science and Technology (2020KY638).
Ethics statement
All surgical interventions, treatments, and postoperative animal care procedures are strictly implemented following the “Guidelines for the Care and Use of Laboratory Animals of the National. Institutes of Health” and are approved by the Animal Care and Use Committee of Wenzhou Medical University (wydw2020-0653).
Conflict of interest
The authors declare no competing interests.
Footnotes
Edited by G.M. Fimia
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Ben Wang, Yifeng Shi
Contributor Information
Zhenghua Hong, Email: hongzh@ezmed.com.
Xiangyang Wang, Email: xiangyangwang@wmu.edu.cn.
Xiaolei Zhang, Email: zhangxiaolei@wmu.edu.cn.
Supplementary information
The online version contains supplementary material available at 10.1038/s41419-021-03791-9.
References
- 1.Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br. Med. Bull. 2013;105:185–199. doi: 10.1093/bmb/lds038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Blagojevic M, Jinks C, Jeffery A, Jordan KP. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr. Cartil. 2010;18:24–33. doi: 10.1016/j.joca.2009.08.010. [DOI] [PubMed] [Google Scholar]
- 3.Sun MM, Beier F, Pest MA. Recent developments in emerging therapeutic targets of osteoarthritis. Curr. Opin. Rheumatol. 2017;29:96–102. doi: 10.1097/BOR.0000000000000351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gu YT, et al. Research progress on osteoarthritis treatment mechanisms. Biomed. Pharmacother. 2017;93:1246–1252. doi: 10.1016/j.biopha.2017.07.034. [DOI] [PubMed] [Google Scholar]
- 5.Lewis JS, et al. Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee. Osteoarthr. Cartil. 2011;19:864–873. doi: 10.1016/j.joca.2011.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Arellano Perez Vertti RD, et al. Cartilage oligomeric matrix protein levels in Type 2 diabetes associated with primary knee osteoarthritis patients. Genet. Test. Mol. Biomark. 2019;23:16–22. doi: 10.1089/gtmb.2018.0184. [DOI] [PubMed] [Google Scholar]
- 7.King KB, Rosenthal AK. The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms. Osteoarthr. Cartil. 2015;23:841–850. doi: 10.1016/j.joca.2015.03.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cohen MP, Surma ML. Effect of diabetes on in vivo metabolism of [35S]-labeled glomerular basement membrane. Diabetes. 1984;33:8–12. doi: 10.2337/diab.33.1.8. [DOI] [PubMed] [Google Scholar]
- 9.Umpierrez GE, Zlatev T, Spanheimer RG. Correction of altered collagen metabolism in diabetic animals with insulin therapy. Matrix. 1989;9:336–342. doi: 10.1016/S0934-8832(89)80010-1. [DOI] [PubMed] [Google Scholar]
- 10.Silberberg R, Hirshberg GE, Lesker P. Enzyme studies in the articular cartilage of diabetic rats and of rats bearing transplanted pancreatic islets. Diabetes. 1977;26:732–735. doi: 10.2337/diab.26.8.732. [DOI] [PubMed] [Google Scholar]
- 11.Kayal RA, et al. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J. Bone Min. Res. 2007;22:560–568. doi: 10.1359/jbmr.070115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Alblowi J, et al. Chemokine expression is upregulated in chondrocytes in diabetic fracture healing. Bone. 2013;53:294–300. doi: 10.1016/j.bone.2012.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Pessler F, et al. The synovitis of “non-inflammatory” orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis. Ann. Rheum. Dis. 2008;67:1184–1187. doi: 10.1136/ard.2008.087775. [DOI] [PubMed] [Google Scholar]
- 14.Guariguata L, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pr. 2014;103:137–149. doi: 10.1016/j.diabres.2013.11.002. [DOI] [PubMed] [Google Scholar]
- 15.Vos T, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–2196. doi: 10.1016/S0140-6736(12)61729-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Giampieri F, et al. Autophagy in human health and disease: novel therapeutic opportunities. Antioxid. Redox Signal. 2019;30:577–634. doi: 10.1089/ars.2017.7234. [DOI] [PubMed] [Google Scholar]
- 17.Abounit K, Scarabelli TM, McCauley RB. Autophagy in mammalian cells. World J. Biol. Chem. 2012;3:1–6. doi: 10.4331/wjbc.v3.i1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Caramés B, Taniguchi N, Otsuki S, Blanco FJ, Lotz M. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 2010;62:791–801. doi: 10.1002/art.27305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Goldring MB, Goldring SR. Osteoarthritis. J. Cell. Physiol. 2007;213:626–634. doi: 10.1002/jcp.21258. [DOI] [PubMed] [Google Scholar]
- 20.Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27–42. doi: 10.1016/j.cell.2007.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Jiang L, et al. Apoptosis, senescence, and autophagy in rat nucleus pulposus cells: implications for diabetic intervertebral disc degeneration. J. Orthop. Res. 2013;31:692–702. doi: 10.1002/jor.22289. [DOI] [PubMed] [Google Scholar]
- 22.Ribeiro M, et al. Diabetes-accelerated experimental osteoarthritis is prevented by autophagy activation. Osteoarthr. Cartil. 2016;24:2116–2125. doi: 10.1016/j.joca.2016.06.019. [DOI] [PubMed] [Google Scholar]
- 23.Ribeiro M, López de Figueroa P, Blanco FJ, Mendes AF, Caramés B. Insulin decreases autophagy and leads to cartilage degradation. Osteoarthr. Cartil. 2016;24:731–739. doi: 10.1016/j.joca.2015.10.017. [DOI] [PubMed] [Google Scholar]
- 24.Zhou DM, et al. Metformin inhibits high glucose-induced smooth muscle cell proliferation and migration. Aging. 2020;12:5352–5361. doi: 10.18632/aging.102955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chae CW, et al. High glucose-mediated PICALM and mTORC1 modulate processing of amyloid precursor protein via endosomal abnormalities. Br. J. Pharm. 2020;177:3828–3847. doi: 10.1111/bph.15131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zhao LG, et al. Mibefradil alleviates high-glucose-induced cardiac hypertrophy by inhibiting PI3K/Akt/mTOR-mediated autophagy. J. Cardiovasc. Pharm. 2020;76:246–254. doi: 10.1097/FJC.0000000000000844. [DOI] [PubMed] [Google Scholar]
- 27.Guo X, et al. 1,25-Dihydroxyvitamin D attenuates diabetic cardiac autophagy and damage by vitamin D receptor-mediated suppression of FoxO1 translocation. J. Nutr. Biochem. 2020;80:108380. doi: 10.1016/j.jnutbio.2020.108380. [DOI] [PubMed] [Google Scholar]
- 28.Han D, et al. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels. J. Cell. Physiol. 2020;235:8839–8851. doi: 10.1002/jcp.29727. [DOI] [PubMed] [Google Scholar]
- 29.Luc, K., Schramm-Luc A., Guzik T. J. & Mikolajczyk, T. P. Oxidative stress and inflammatory markers in prediabetes and diabetes. J. Physiol. Pharmacol.70, 2019. [DOI] [PubMed]
- 30.Singh, H. et al. Protective role of Phyllanthusfraternus in alloxan-induced diabetes in rats. J. Ayurveda Integr. Med.11, 391–398 (2020). [DOI] [PMC free article] [PubMed]
- 31.Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S. AMPK in the brain: its roles in energy balance and neuroprotection. J. Neurochem. 2009;109:17–23. doi: 10.1111/j.1471-4159.2009.05916.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Garcia D, Shaw RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol. Cell. 2017;66:789–800. doi: 10.1016/j.molcel.2017.05.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lin WJ, Kuang HY. Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells. Autophagy. 2014;10:1692–1701. doi: 10.4161/auto.36076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Cardaci S, Filomeni G, Ciriolo MR. Redox implications of AMPK-mediated signal transduction beyond energetic clues. J. Cell Sci. 2012;125:2115–2125. doi: 10.1242/jcs.095216. [DOI] [PubMed] [Google Scholar]
- 35.Yu SM, Kim SJ. The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes. Int. J. Mol. Med. 2015;35:325–332. doi: 10.3892/ijmm.2014.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377–388. doi: 10.1038/cdd.2014.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Husa M, Petursson F, Lotz M, Terkeltaub R, Liu-Bryan R. C/EBP homologous protein drives pro-catabolic responses in chondrocytes. Arthritis Res. Ther. 2013;15:R218. doi: 10.1186/ar4415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Caterson B, Baker JR, Christner JE, Pollok BA, Rostand KS. Diabetes and osteoarthritis. Ala. J. Med. Sci. 1980;17:292–299. [PubMed] [Google Scholar]
- 39.Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad. Med. J. 2012;88:240–242. doi: 10.1136/pgmj.2010.146399rep. [DOI] [PubMed] [Google Scholar]
- 40.Schwarz S, Mrosewski I, Silawal S, Schulze-Tanzil G. The interrelation of osteoarthritis and diabetes mellitus: considering the potential role of interleukin-10 and in vitro models for further analysis. Inflamm. Res. 2018;67:285–300. doi: 10.1007/s00011-017-1121-8. [DOI] [PubMed] [Google Scholar]
- 41.Yang Z, et al. Prokineticin 2 (PK2) rescues cardiomyocytes from high glucose/high palmitic acid-induced damage by regulating the AKT/GSK3β pathway in vitro. Oxid. Med. Cell. Longev. 2020;2020:3163629. doi: 10.1155/2020/3163629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Jones DP. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 2008;295:C849–C868. doi: 10.1152/ajpcell.00283.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Pal S, Rao GN, Pal A. High glucose-induced ROS accumulation is a critical regulator of ERK1/2-Akt-tuberin-mTOR signalling in RGC-5 cells. Life Sci. 2020;256:117914. doi: 10.1016/j.lfs.2020.117914. [DOI] [PubMed] [Google Scholar]
- 44.Zhang W., Sui Y. CircBPTF knockdown ameliorates high glucose-induced inflammatory injuries and oxidative stress by targeting the miR-384/LIN28B axis in human umbilical vein endothelial cells. Mol. Cell. Biochem.471, 101–111 (2020). [DOI] [PubMed]
- 45.Li R, et al. NGF attenuates high glucose-induced ER stress, preventing Schwann cell apoptosis by activating the PI3K/Akt/GSK3β and ERK1/2 pathways. Neurochem. Res. 2017;42:3005–3018. doi: 10.1007/s11064-017-2333-6. [DOI] [PubMed] [Google Scholar]
- 46.Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid. Redox Signal. 2011;14:2179–2190. doi: 10.1089/ars.2010.3488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cimini S, Rizzardini M, Biella G, Cantoni L. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. J. Neurochem. 2014;129:413–425. doi: 10.1111/jnc.12642. [DOI] [PubMed] [Google Scholar]
- 48.Essick EE, Sam F. Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid. Med. Cell. Longev. 2010;3:168–177. doi: 10.4161/oxim.3.3.12106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Filomeni G, Desideri E, Cardaci S, Rotilio G, Ciriolo MR. Under the ROS…thiol network is the principal suspect for autophagy commitment. Autophagy. 2010;6:999–1005. doi: 10.4161/auto.6.7.12754. [DOI] [PubMed] [Google Scholar]
- 50.Levonen AL, Hill BG, Kansanen E, Zhang J, Darley-Usmar VM. Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radic. Biol. Med. 2014;71:196–207. doi: 10.1016/j.freeradbiomed.2014.03.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Zhu C, et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J. Neurochem. 2006;96:1016–1027. doi: 10.1111/j.1471-4159.2005.03639.x. [DOI] [PubMed] [Google Scholar]
- 52.Almasieh M, et al. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retinal Eye Res. 2012;31:152–181. doi: 10.1016/j.preteyeres.2011.11.002. [DOI] [PubMed] [Google Scholar]
- 53.Adhami F, Schloemer A, Kuan CY. The roles of autophagy in cerebral ischemia. Autophagy. 2007;3:42–44. doi: 10.4161/auto.3412. [DOI] [PubMed] [Google Scholar]
- 54.Huang J, et al. Activation of antibacterial autophagy by NADPH oxidases. Proc. Natl. Acad. Sci. USA. 2009;106:6226–6231. doi: 10.1073/pnas.0811045106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Schweers RL, et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc. Natl. Acad. Sci. USA. 2007;104:19500–19505. doi: 10.1073/pnas.0708818104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Tracy K, et al. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol. Cell. Biol. 2007;27:6229–6242. doi: 10.1128/MCB.02246-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008;183:795–803. doi: 10.1083/jcb.200809125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Scherz-Shouval R, et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 2007;26:1749–1760. doi: 10.1038/sj.emboj.7601623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Rodríguez-Muela N, Germain F, Mariño G, Fitze PS, Boya P. Autophagy promotes survival of retinal ganglion cells after optic nerve axotomy in mice. Cell Death Differ. 2012;19:162–169. doi: 10.1038/cdd.2011.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011;25:1895–1908. doi: 10.1101/gad.17420111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Oakhill JS, et al. AMPK is a direct adenylate charge-regulated protein kinase. Science. 2011;332:1433–1435. doi: 10.1126/science.1200094. [DOI] [PubMed] [Google Scholar]
- 62.Jiang, P. et al. Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53. Mol. Cell81, 629–637 (2021). [DOI] [PubMed]
- 63.Nakagawa S, et al. N-acetylcysteine prevents nitric oxide-induced chondrocyte apoptosis and cartilage degeneration in an experimental model of osteoarthritis. J. Orthop. Res. 2010;28:156–163. doi: 10.1002/jor.20976. [DOI] [PubMed] [Google Scholar]
- 64.Liu TY, et al. FNDC5 alleviates hepatosteatosis by restoring AMPK/mTOR-mediated autophagy, fatty acid oxidation, and lipogenesis in mice. Diabetes. 2016;65:3262–3275. doi: 10.2337/db16-0356. [DOI] [PubMed] [Google Scholar]
- 65.Pigna E, et al. Aerobic exercise and pharmacological treatments counteract cachexia by modulating autophagy in colon cancer. Sci. Rep. 2016;6:26991. doi: 10.1038/srep26991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Wang, K. et al Genistein protects intervertebral discs from degeneration via Nrf2-mediated antioxidant defense system: An in vitro and in vivo study. J. Cell. Physiol.10.1002/jcp.28301 (2019). [DOI] [PubMed]
- 67.Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr. Cartil. 2010;18:S17–S23. doi: 10.1016/j.joca.2010.05.025. [DOI] [PubMed] [Google Scholar]
- 68.Permuy M, et al. Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model. BMC Vet. Res. 2015;11:143. doi: 10.1186/s12917-015-0458-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Goldring SR. Role of bone in osteoarthritis pathogenesis. Med. Clin. North Am. 2009;93:25–35. doi: 10.1016/j.mcna.2008.09.006. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.